Skip to content

Staar Surgical STAA Free cash flow margin

Free cash flow margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.5%-4.3pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
9.8%-2.8pp
IAR
Integra LifeSciencesIART
3.8%-6.3pp
ITG
Integer HoldingsITGR
5.4%-1.0pp
Glaukos logo
GlaukosGKOS
-13.2%-3.9pp
HRO
HarrowHROW
5.7%+5.0pp

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+47.4%
Enterprise value$1.35B+61.6%
P/S+1.5×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on trailing twelve months.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's free cash flow margin?
Staar Surgical (STAA) reported free cash flow margin of -19.6% in Q1 2026.
How has Staar Surgical's free cash flow margin changed year-over-year?
Staar Surgical's free cash flow margin decreased by 74.1% year-over-year, from -11.2% to -19.6%.
What is the long-term trend for Staar Surgical's free cash flow margin?
Over 4 years (2020 to 2025), Staar Surgical's free cash flow margin has grown at a 22.8% compound annual growth rate (CAGR), from 7.7% to -17.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.